Delta Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Delta Capital Management's DGX Position: Q3 2026 in Review
Delta Capital Management increased its Quest Diagnostics (DGX) stake by 0.33% in Q3 2026, buying an estimated $13.9K and bringing the position to 18,000 shares worth $4.2M. The position accounts for 2.03% of the portfolio, ranked #11.
Delta Capital Management first reported a position in DGX in Q1 2021 and has held it in 23 quarters since. 1,139 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Delta Capital Management held 18,000 shares of Quest Diagnostics worth $4.2M as of Q3 2026.
- Delta Capital Management bought 60 Quest Diagnostics shares in Q3 2026, an estimated $13.9K.
- Quest Diagnostics made up 2.03% of Delta Capital Management's portfolio in Q3 2026, its #11 holding.
- Delta Capital Management first reported a position in Quest Diagnostics in Q1 2021 and has held it in 23 quarters since.
- 1,139 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Delta Capital Management's 13F filing for Q3 2026, filed 16 Oct 2026.